APP and Alzheimer disease: It has also been confirmed that AD pathologic markers, oligomeric Aβ and Aβ plaque load, could be reduced by LG and microglial activation is decreased and memory behaviors are improved in APPswe/PS1_E9 (APP/PS1) mouse model after using LG (74).